Data is not available at this time.
Hirakawa Hewtech Corp. operates as a diversified industrial conglomerate with a strong focus on precision cable manufacturing and specialized electronic components. The company serves high-growth sectors such as medical equipment, industrial automation, and digital infrastructure, leveraging its expertise in super-fine coaxial cables, wire harnesses, and digital interface solutions. Its product portfolio includes critical components for robotics, medical devices, and broadcasting equipment, positioning it as a niche supplier with technical differentiation. Hirakawa Hewtech maintains a competitive edge through vertical integration, offering not only cables but also related processed goods and shielding products. The company’s expansion into medical tubing and contract electrical work diversifies its revenue streams while reinforcing its industrial foothold. With operations in Japan and internationally, it balances domestic stability with selective global opportunities, though its market share remains concentrated in specialized B2B applications rather than mass-market segments.
Hirakawa Hewtech reported revenue of JPY 29.3 billion for FY2024, with net income of JPY 1.44 billion, reflecting a net margin of approximately 4.9%. Operating cash flow stood at JPY 4.2 billion, indicating solid cash conversion despite moderate profitability. Capital expenditures of JPY 1.1 billion suggest disciplined reinvestment, aligning with its niche manufacturing focus.
The company’s diluted EPS of JPY 102.8 underscores its ability to generate earnings despite operating in capital-intensive segments. Its low beta (0.31) implies stable earnings relative to market volatility, though this may also reflect limited growth expectations. Cash reserves of JPY 12.7 billion provide flexibility for R&D or strategic acquisitions.
Hirakawa Hewtech maintains a robust balance sheet, with JPY 12.7 billion in cash against JPY 3.2 billion in total debt, yielding a net cash position. This conservative leverage supports resilience in cyclical industries. The debt-to-equity ratio remains manageable, aligning with its asset-light subcontracting model.
Growth appears steady but unspectacular, with revenue likely tied to industrial demand cycles. The dividend of JPY 48 per share signals a commitment to shareholder returns, though the payout ratio leaves room for reinvestment. International expansion and medical tubing could drive future upside.
At a market cap of JPY 21.8 billion, the stock trades at ~15x net income, a modest multiple reflecting its niche positioning. Low beta and stable cash flows may appeal to defensive investors, but limited sector tailwinds could cap valuation re-rating.
Hirakawa Hewtech’s technical expertise and diversified industrial exposure provide stability, but growth hinges on penetrating higher-margin medical and automation markets. Its strong balance sheet and cash reserves position it to weather downturns, though innovation will be critical to offsetting pricing pressures in cable manufacturing.
Company filings, Bloomberg
show cash flow forecast
| Fiscal year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | 2050 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |